Release Date: 14/06/16 08:18 Summary: Matilda Approvals & Funding Drawdown-BLK.AX Price Sensitive: Yes Download Document 1.15MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%